Deafness
Not yet recruitingSafety, Tolerability and Efficacy of Intracochlear SENS-601 in Children with GJB2‑Related Hearing Loss
- Disease:Deafness
- Substances:–
France- Participants:0–17 years
- Sponsor:Sensorion
Rare diseases
Investigational molecules
Locations

375 Rue Du Professeur Blayac, 34080 Montpellier, France
Sensorion focuses on cisplatin-induced hearing loss, with clinical research centered on protecting auditory function in adults exposed to ototoxicity associated with cancer treatment.
The sponsor’s research activity in this area reflects a therapeutic interest in preserving inner ear function in patients receiving cisplatin.
Sensorion runs clinical trials in conditions such as Deafness, Deafness bilateral, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
France
France
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.